Our system has noticed that you are based in , but the current country setting is . Select country
Financial News
-
May 20, 2022Read more
Annual Shareholders’ Meeting Approves Record Dividend
-
Apr 28, 2022Read more
WACKER achieves sales above €2 billion for the first time in Q1 2022 and more than doubles EBITDA year over year
-
Apr 11, 2022Read more
Pandemic Preparedness: WACKER and CordenPharma Will Produce mRNA Vaccines for Germany When Needed
-
Mar 29, 2022Read more
Targets for 2030: WACKER Accelerates Growth with High Profitability
-
Mar 15, 2022Read more
After Record Sales in 2021, WACKER Continues its Growth in 2022